• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌致癌分化分子标志物的鉴定

Identification of molecular markers for the oncogenic differentiation of hepatocellular carcinoma.

作者信息

Yu Gyung Ran, Kim Seong Hun, Park Seon Hwa, Cui Xiang Dan, Xu Dong Yuan, Yu Hee Chul, Cho Baik Hwan, Yeom Young Il, Kim Sang Soo, Kim Sang Bae, Chu In Sun, Kim Dae Ghon

机构信息

Division of Gastroenterology and Hepatology, The Research Institute of Clinical Medicine, Department of Internal Medicine, Chonbuk National University Medical School and Hospital, Jeonju 561-712, Korea.

出版信息

Exp Mol Med. 2007 Oct 31;39(5):641-52. doi: 10.1038/emm.2007.70.

DOI:10.1038/emm.2007.70
PMID:18059140
Abstract

The aim of this study was to identify molecular markers associated with oncogenic differentiation in hepatocellular carcinoma (HCC). Using an unsupervised clustering method with a cDNA microarray, HCC (T) gene expression profiles and corresponding non-tumor tissues (NT) from 40 patients were analyzed. Of total 217 genes, 72 were expressed preferentially in HCC tissues. Among 186 differentially regulated genes, there were molecular chaperone and tumor suppressor gene clusters in the Edmondson grades I and II (GI/II) subclass compared with the liver cirrhosis (LC) subclass. The Edmondson grades III and IV (GIII/IV) subclass with a poor survival (P=0.0133) contained 122 differentially regulated genes with a cluster containing various metastasis- and invasion-related genes compared with the GI/II subclass. Immunohistochemical analysis revealed that ANXA2, one of the 72 genes preferentially expressed in HCC, was over-expressed in the sinusoidal endothelium and in malignant hepatocytes in HCC. The genes identified in the HCC subclasses will be useful molecular markers for the genesis and progression of HCC. In addition, ANXA2 might be a novel marker for tumor angiogenesis in HCC.

摘要

本研究的目的是鉴定与肝细胞癌(HCC)致癌分化相关的分子标志物。采用cDNA微阵列无监督聚类方法,分析了40例患者的HCC(T)基因表达谱及相应的非肿瘤组织(NT)。在总共217个基因中,72个在HCC组织中优先表达。在186个差异调节基因中,与肝硬化(LC)亚类相比,Edmondson I级和II级(GI/II)亚类中有分子伴侣和肿瘤抑制基因簇。生存较差的Edmondson III级和IV级(GIII/IV)亚类(P=0.0133)与GI/II亚类相比包含122个差异调节基因,其中一个簇包含各种与转移和侵袭相关的基因。免疫组织化学分析显示,72个在HCC中优先表达的基因之一ANXA2,在HCC的窦状内皮和恶性肝细胞中过度表达。在HCC亚类中鉴定出的基因将是HCC发生和进展的有用分子标志物。此外,ANXA2可能是HCC肿瘤血管生成的新标志物。

相似文献

1
Identification of molecular markers for the oncogenic differentiation of hepatocellular carcinoma.肝细胞癌致癌分化分子标志物的鉴定
Exp Mol Med. 2007 Oct 31;39(5):641-52. doi: 10.1038/emm.2007.70.
2
Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma.膜联蛋白A2的表达和磷酸化在肝细胞癌中上调。
Int J Oncol. 2008 Dec;33(6):1157-63.
3
Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis.基因组分析显示,RhoC是预后不良的肝细胞癌的一个潜在标志物。
Br J Cancer. 2004 Jun 14;90(12):2349-55. doi: 10.1038/sj.bjc.6601749.
4
Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.利用表达序列标签对人乙肝病毒和/或丙肝病毒相关的肝癌细胞进行基因表达谱分析。
Int J Oncol. 2006 Aug;29(2):315-27.
5
Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.非癌性肝组织的特定基因表达谱可预测丙型肝炎病毒阳性患者发生多中心肝细胞癌的风险。
Ann Surg Oncol. 2006 Jul;13(7):947-54. doi: 10.1245/ASO.2006.07.018. Epub 2006 May 23.
6
Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.富含表皮生长因子的纤维连接蛋白样细胞外基质蛋白 1(EFEMP1),一种使用双重组合微阵列分析在肝细胞癌中检测到的新型肿瘤抑制基因。
Ann Surg Oncol. 2010 Mar;17(3):923-32. doi: 10.1245/s10434-009-0790-0. Epub 2009 Nov 7.
7
Gene expression profiling of fixed tissues identified hypoxia-inducible factor-1α, VEGF, and matrix metalloproteinase-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma.固定组织的基因表达谱分析确定缺氧诱导因子-1α、VEGF 和基质金属蛋白酶-2 为肝癌淋巴结转移的生物标志物。
Clin Cancer Res. 2011 Aug 15;17(16):5463-72. doi: 10.1158/1078-0432.CCR-10-3096. Epub 2011 Jun 28.
8
Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling.通过基因表达谱分析从发育异常结节到肝细胞癌的分子变化。
Hepatology. 2005 Oct;42(4):809-18. doi: 10.1002/hep.20878.
9
Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search.通过全基因组搜索鉴定BASP1和SRD5A2的新型异常甲基化用于肝细胞癌的早期诊断
Int J Oncol. 2008 Nov;33(5):949-58.
10
[Determination of expression of eight p53-related genes in hepatocellular carcinoma with tissue microarrays].[应用组织芯片技术检测8种p53相关基因在肝癌中的表达]
Ai Zheng. 2003 Jul;22(7):680-5.

引用本文的文献

1
Role of the Annexin A protein family in liver diseases: insights and therapeutic opportunities.膜联蛋白A蛋白家族在肝脏疾病中的作用:见解与治疗机遇
Front Pharmacol. 2025 Jul 11;16:1569927. doi: 10.3389/fphar.2025.1569927. eCollection 2025.
2
Comprehensive RNA-Seq Gene Co-Expression Analysis Reveals Consistent Molecular Pathways in Hepatocellular Carcinoma across Diverse Risk Factors.综合RNA测序基因共表达分析揭示了不同风险因素下肝细胞癌中一致的分子通路。
Biology (Basel). 2024 Sep 26;13(10):765. doi: 10.3390/biology13100765.
3
A de novo missense mutation in MPP2 confers an increased risk of Vogt-Koyanagi-Harada disease as shown by trio-based whole-exome sequencing.
通过基于三核苷酸的全外显子组测序发现,MPP2 中的一个新的错义突变可增加 Vogt-Koyanagi-Harada 病的风险。
Cell Mol Immunol. 2023 Nov;20(11):1379-1392. doi: 10.1038/s41423-023-01088-9. Epub 2023 Oct 12.
4
ANXA2 is a potential biomarker for cancer prognosis and immune infiltration: A systematic pan-cancer analysis.膜联蛋白A2是癌症预后和免疫浸润的潜在生物标志物:一项全癌种系统分析。
Front Genet. 2023 Jan 12;14:1108167. doi: 10.3389/fgene.2023.1108167. eCollection 2023.
5
Clinicopathological-Associated Regulatory Network of Deregulated circRNAs in Hepatocellular Carcinoma.肝细胞癌中失调环状RNA的临床病理相关调控网络
Cancers (Basel). 2021 Jun 2;13(11):2772. doi: 10.3390/cancers13112772.
6
Cell Surface Proteins in Hepatocellular Carcinoma: From Bench to Bedside.肝细胞癌中的细胞表面蛋白:从实验室到临床
Vaccines (Basel). 2020 Jan 24;8(1):41. doi: 10.3390/vaccines8010041.
7
Identification and Comparison of Differentiation-Related Proteins in Hepatocellular Carcinoma Tissues by Proteomics.蛋白质组学技术对肝癌组织中分化相关蛋白的鉴定与比较
Technol Cancer Res Treat. 2017 Dec;16(6):1092-1101. doi: 10.1177/1533034617732426. Epub 2017 Sep 25.
8
MiR-3613-3p affects cell proliferation and cell cycle in hepatocellular carcinoma.微小RNA-3613-3p影响肝细胞癌的细胞增殖和细胞周期。
Oncotarget. 2017 Oct 10;8(54):93014-93028. doi: 10.18632/oncotarget.21745. eCollection 2017 Nov 3.
9
Haptoglobin expression correlates with tumor differentiation and five-year overall survival rate in hepatocellular carcinoma.结合珠蛋白表达与肝细胞癌的肿瘤分化及五年总生存率相关。
PLoS One. 2017 Feb 3;12(2):e0171269. doi: 10.1371/journal.pone.0171269. eCollection 2017.
10
Accuracy of novel diagnostic biomarkers for hepatocellular carcinoma: An update for clinicians (Review).肝细胞癌新型诊断生物标志物的准确性:临床医生最新进展(综述)
Oncol Rep. 2016 Aug;36(2):613-25. doi: 10.3892/or.2016.4842. Epub 2016 Jun 1.